Letter from the Editors

The first approach to evaluating infectious disease clinically with radionuclide methodology utilized gallium-67 citrate, which was developed as a carrier-free agent at the Oak Ridge National Laboratories. In an early issue of Seminars, Dr Raymond Hayes shared some of his memories of its early usage as a tumor-seeking agent and, subsequently, for detecting sites of infection.1 The number of gallium studies performed clinically peaked in the 1980s during the increasing prevalence of HIV and its associated complication of Pneumocystis carinii pneumonia (PCP).
Source: Seminars in Nuclear Medicine - Category: Nuclear Medicine Authors: Source Type: research